Teplizumab approval for type 1 diabetes in the USA
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) Editorial |
| Language: | English |
| Published: |
February 2023
|
| In: |
The lancet. Diabetes & Endocrinology
Year: 2023, Volume: 11, Issue: 2, Pages: 78-80 |
| ISSN: | 2213-8595 |
| DOI: | 10.1016/S2213-8587(22)00384-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S2213-8587(22)00384-9 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2213858722003849 |
| Author Notes: | David Beran, Carol Abidha, Amanda Adler, Carine de Beaufort, Molly Lepeska, Naomi Levitt, Elizabeth Pfiester, Jessica H Zafra-Tanaka, Edwin AM Gale |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1857679040 | ||
| 003 | DE-627 | ||
| 005 | 20240307060046.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230823s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S2213-8587(22)00384-9 |2 doi | |
| 035 | |a (DE-627)1857679040 | ||
| 035 | |a (DE-599)KXP1857679040 | ||
| 035 | |a (OCoLC)1425212109 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Beran, David |e VerfasserIn |0 (DE-588)1299955509 |0 (DE-627)1857679679 |4 aut | |
| 245 | 1 | 0 | |a Teplizumab approval for type 1 diabetes in the USA |c David Beran, Carol Abidha, Amanda Adler, Carine de Beaufort, Molly Lepeska, Naomi Levitt, Elizabeth Pfiester, Jessica H Zafra-Tanaka, Edwin AM Gale |
| 264 | 1 | |c February 2023 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online verfügbar: 6. Januar 2023, Artikelversion: 24. Januar 2023 | ||
| 500 | |a Gesehen am 23.08.2023 | ||
| 700 | 1 | |a Abidha, Carol Akinyi |e VerfasserIn |0 (DE-588)121605780X |0 (DE-627)1727151933 |4 aut | |
| 700 | 1 | |a Adler, Amanda |e VerfasserIn |4 aut | |
| 700 | 1 | |a de Beaufort, Carine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lepeska, Molly |e VerfasserIn |4 aut | |
| 700 | 1 | |a Levitt, Naomi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfiester, Elizabeth |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zafra-Tanaka, Jessica H |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gale, Edwin AM |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The lancet. Diabetes & Endocrinology |d Oxford : Elsevier, 2013 |g 11(2023), 2 vom: Feb., Seite 78-80 |w (DE-627)740705059 |w (DE-600)2709541-1 |w (DE-576)380789566 |x 2213-8595 |7 nnas |a Teplizumab approval for type 1 diabetes in the USA |
| 773 | 1 | 8 | |g volume:11 |g year:2023 |g number:2 |g month:02 |g pages:78-80 |g extent:3 |a Teplizumab approval for type 1 diabetes in the USA |
| 856 | 4 | 0 | |u https://doi.org/10.1016/S2213-8587(22)00384-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S2213858722003849 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230823 | ||
| 993 | |a Editorial | ||
| 994 | |a 2023 | ||
| 998 | |g 121605780X |a Abidha, Carol Akinyi |m 121605780X:Abidha, Carol Akinyi |d 50000 |e 50000PA121605780X |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1857679040 |e 4369662532 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"origin":[{"dateIssuedDisp":"February 2023","dateIssuedKey":"2023"}],"title":[{"title":"Teplizumab approval for type 1 diabetes in the USA","title_sort":"Teplizumab approval for type 1 diabetes in the USA"}],"recId":"1857679040","type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["David Beran, Carol Abidha, Amanda Adler, Carine de Beaufort, Molly Lepeska, Naomi Levitt, Elizabeth Pfiester, Jessica H Zafra-Tanaka, Edwin AM Gale"]},"relHost":[{"note":["Gesehen am 25.03.13"],"titleAlt":[{"title":"The lancet <London> / Diabetes & Endocrinology"}],"title":[{"title":"The lancet","partname":"Diabetes & Endocrinology","title_sort":"lancet"}],"origin":[{"dateIssuedDisp":"2013-","publisher":"Elsevier","dateIssuedKey":"2013","publisherPlace":"Oxford"}],"pubHistory":["2013 -"],"language":["eng"],"id":{"eki":["740705059"],"issn":["2213-8595"],"zdb":["2709541-1"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Teplizumab approval for type 1 diabetes in the USAThe lancet. Diabetes & Endocrinology","part":{"volume":"11","text":"11(2023), 2 vom: Feb., Seite 78-80","extent":"3","issue":"2","pages":"78-80","year":"2023"},"recId":"740705059"}],"person":[{"display":"Beran, David","given":"David","family":"Beran","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Abidha, Carol Akinyi","family":"Abidha","given":"Carol Akinyi","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Amanda","family":"Adler","display":"Adler, Amanda","roleDisplay":"VerfasserIn","role":"aut"},{"display":"de Beaufort, Carine","family":"de Beaufort","given":"Carine","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Lepeska","given":"Molly","display":"Lepeska, Molly","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Levitt, Naomi","given":"Naomi","family":"Levitt","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Pfiester, Elizabeth","given":"Elizabeth","family":"Pfiester","role":"aut","roleDisplay":"VerfasserIn"},{"given":"Jessica H","family":"Zafra-Tanaka","display":"Zafra-Tanaka, Jessica H","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gale, Edwin AM","family":"Gale","given":"Edwin AM"}],"physDesc":[{"extent":"3 S."}],"note":["Online verfügbar: 6. Januar 2023, Artikelversion: 24. Januar 2023","Gesehen am 23.08.2023"],"id":{"doi":["10.1016/S2213-8587(22)00384-9"],"eki":["1857679040"]}} | ||
| SRT | |a BERANDAVIDTEPLIZUMAB2023 | ||